Cite
Coughlan JJ, Aytekin A, Lahu S, et al. Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical Trial. JAMA Cardiol. 2021;6(10):1121-1129doi: 10.1001/jamacardio.2021.2228.
Coughlan, J. J., Aytekin, A., Lahu, S., Ndrepepa, G., Menichelli, M., Mayer, K., Wöhrle, J., Bernlochner, I., Gewalt, S., Witzenbichler, B., Hochholzer, W., Sibbing, D., Cassese, S., Angiolillo, D. J., Hemetsberger, R., Valina, C., Müller, A., Kufner, S., Liebetrau, C., Xhepa, E., Hapfelmeier, A., Sager, H. B., Joner, M., Fusaro, M., Richardt, G., Laugwitz, K. L., Neumann, F. J., Schunkert, H., Schüpke, S., & Kastrati, A. (2021). Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical Trial. JAMA cardiology, 6(10), 1121-1129. https://doi.org/10.1001/jamacardio.2021.2228
Coughlan, J J, et al. "Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical Trial." JAMA cardiology vol. 6,10 (2021): 1121-1129. doi: https://doi.org/10.1001/jamacardio.2021.2228
Coughlan JJ, Aytekin A, Lahu S, Ndrepepa G, Menichelli M, Mayer K, Wöhrle J, Bernlochner I, Gewalt S, Witzenbichler B, Hochholzer W, Sibbing D, Cassese S, Angiolillo DJ, Hemetsberger R, Valina C, Müller A, Kufner S, Liebetrau C, Xhepa E, Hapfelmeier A, Sager HB, Joner M, Fusaro M, Richardt G, Laugwitz KL, Neumann FJ, Schunkert H, Schüpke S, Kastrati A. Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical Trial. JAMA Cardiol. 2021 Oct 01;6(10):1121-1129. doi: 10.1001/jamacardio.2021.2228. PMID: 34190967; PMCID: PMC8246339.
Copy
Download .nbib